Travis Clifton

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 28, 2026
Phase II trial of encapsulated rapamycin to reduce polyp burden associated with familial adenomatous polyposis.

|Jun 01, 2023
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.

Anne E O'Shea, Guy T Clifton, Na Qiao

|May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.

Robert C Chick, Mark B Faries, Diane F Hale

|Jan 30, 2021
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression.

Phillip M Kemp Bohan, Robert C Chick, Anne E O'Shea

|Feb 20, 2020
Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer.

G Travis Clifton, Diane Hale, Timothy J Vreeland

|Jul 06, 2019
Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.

Tommy A Brown, Kevin Byrd, Timothy J Vreeland

Pageof 1

Frequent Collaborators

4 joint publications

Timothy J Vreeland

2 joint publications

Robert C Chick

2 joint publications

George Peoples

1 joint publications

Rashmi K Murthy